Diabetologia

Article	Citations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]	675
Up Front	405
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study	202
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 2025	176
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities	171
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory	150
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo	127
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	126
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]	118
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes	111
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study	110
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification	108
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin	94
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study	90
60th EASD Annual Meeting of the European Association for the Study of Diabetes	89
Methodological considerations for interpreting long-term statin use and diabetes incidence	88
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection	87
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq	86
Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative	86
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study	85
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)	81
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes	81
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk	78
Ageing well with diabetes: the role of technology	76
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care	75

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study	74
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people	74
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy	73
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells	72
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes	68
58th EASD Annual Meeting of the European Association for the Study of Diabetes	67
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials	67
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	67
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation	66
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk	66
Daniel Porte Jr, 13 August 1931–13 May 2023	65
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial	65
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open	65
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes	65
Up Front	65
Pinpointing precision medicine for diabetes mellitus	63
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity	62
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome	62
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations	61
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial	60
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap	59
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes	58
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women	58
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy	58
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis	58
Mortality risk for kidney transplant candidates with diabetes: a population cohort study	56
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity	55
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study	55
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data	55
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial	54
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy	53
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals	51
The role of automated insulin delivery technology in diabetes	51
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry	51
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications	50
Bo Hellman, 19 June 1930–4 December 2023	48
The COVID-19 pandemic may be receding but the diabetes pandemic rages on	48
Identification and interpretation of risk factors for Charcot foot	48
Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study	45
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function	45
Technology in the management of diabetes in hospitalised adults	44
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes	43
Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women	43
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets	43
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial	43
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry	42
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover	42
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells	42
tRNA-derived fragments in T lymphocyte–beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice	42
Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes	42

(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study	42
Reversibility of brain glucose kinetics in type 2 diabetes mellitus	41
Comparative physiology and biomimetics in metabolic and environmental health: what can we learn from extreme animal phenotypes?	41
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International	41
Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes	40
Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes	39
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review	39
Declining FXR expression coordinates neonatal beta cell mass development with microbial bile acid metabolism maturation in mice	39
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men	39
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort	39
Genetics of diabetes-associated microvascular complications	38
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial	38
ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes	37
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment	36
Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders	36
Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	36
Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice	36
The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes	36
Up Front	35
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study	35
Women in diabetes research: we can do better. Reply to Bonnefond A [letter]	35
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes	35
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial	35
Genetic variation in the RETN promoter, accompanied by latent sarcopenic obesity, led to insulin resistance in a Japanese cohort: the Toon Genome Study	34
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology	34
Pancreatic exocrine damage induces beta cell stress in zebrafish larvae	34
The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population	33
Up Front	33
The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations	32
Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C	32
Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial	31
Transgender healthcare: metabolic outcomes and cardiovascular risk	31
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy	31
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	31
Accuracy of continuous glucose monitoring in the hospital setting: an observational study	30
Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway	30
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial	30
Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort	30
Incretins: turning the venom into the antidote	30
Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response	30
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT	30
Maturation of beta cells: lessons from in vivo and in vitro models	30
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach	30
Umbilical cord blood DNA methylation in children who later develop type 1 diabetes	30
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation	30
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter	29
Disparities in access to and use of diabetes technologies and therapeutics: a narrative review	29
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis	29
Precision prognostics for the development of complications in diabetes	29
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity	28
Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice	28
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter]	28
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study	28
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort	28
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts	28
Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study	27
Metabolomic and genetic architecture of gestational diabetes subtypes	27
Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans	27
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease	27
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]	27
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational re	27
Correction to: Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	27
BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells	26
Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes	26
Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years	26
Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance	26
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children	26
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementat	26
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis	26
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing	25
METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice	25
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes	25
RFX3 is essential for the generation of functional human pancreatic islets from stem cells	25
Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications	25
Apolipoprotein L genes are novel mediators of inflammation in beta cells	25
The genetics of low and high birthweight and their relationship with cardiometabolic disease	25
Precision nutrition in diabetes: when population-based dietary advice gets personal	24
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app	24
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research	24
The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes	24

Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes	24
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter]	24
Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial	24
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis	24
Women in diabetes research: we can do better	24
Referees 2024	24
Technology advances in diabetes pregnancy: right technology, right person, right time	23
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage	23
TMEM55A-mediated PI5P signalling regulates alpha cell actin depolymerisation and glucagon secretion	23
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes	23
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank	23
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases	23
Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: essential role of macrophage TLR4 in beta cell functionality	23
Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials	22
Identification of SEC16B as a novel regulator of glucose homeostasis	22
Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]	22
Health economic evaluation of a risk-stratified intervention in diabetic kidney disease	22
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications	22
Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter]	22
Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself	22
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial	21
Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4	21
GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes	21
Diabetes and natural and man-made disasters: prevention, preparation, response and recovery	21
Heterogeneity of glycaemic phenotypes in type 1 diabetes	21
Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study	21
Effectiveness and safety of empagliflozin: final results from the EMPRISE study	20
Up Front	20
Spatial proteomics of human diabetic kidney disease, from health to class III	20
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis	20
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models	20
Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation	20
Up Front	20
Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study	20
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia	20
Up Front	20
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits	20
The moral equivalent: 60 years of publishing a scientific journal	20
A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular–kidney complications	20
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants	20
Methodological considerations for interpreting long-term statin use and diabetes incidence. Reply to Ma C, Zeng H [letter]	19
Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes	19
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice	19
European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines	19
Sex differences in type 2 diabetes	19
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers	19
Correction: Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	19
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial	19
Gut microbiota mediate melatonin signalling in association with type 2 diabetes	19
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review	19
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis	19
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies	19
Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK	19
Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors	19
Sarah A. Hills RGN MSc, 28 September 1960–1 May 2023	18
Morning exercise as fasted-state activity. Reply to Chacko E [letter]	18
3D electron microscopy reveals novel ultrastructural changes in the diabetic retinal neurovascular unit	18
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset	18
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question	18
Up Front	18
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?	18
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	18
Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase	18
Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes	18
Up Front	18
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?	17
Phenotypic and genetic classification of diabetes	17
Lifetime history of gestational diabetes and cognitive function in parous women in midlife	17
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes	17
Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes	17
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression	17
Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study	17
Up Front	17
Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes	17
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis	17
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum	17
Pathophysiology of type 2 diabetes in sub-Saharan Africans	17
Compositional analysis of the association between 24 h movement behaviours, HbA1c and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis o	17
An unwelcome inheritance: childhood obesity after diabetes in pregnancy	17
What else can we do to prevent diabetic retinopathy?	16
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease	16
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	16
100 years of glucagon and 100 more	16
Non-autoimmune diabetes in young people from Assam, India: the PHENOEINDY-2 study	16
Up Front	16
Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults	16
High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes	16
Correction: Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 d	16
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a rando	16
Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England	16
Up Front	16
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank	16
Type 2 diabetes and succinate: unmasking an age-old molecule	16
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes	16
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study	16